Tumor-driven paracrine platelet-derived growth factor receptor α signaling is a key determinant of stromal cell recruitment in a model of human lung carcinoma

被引:97
作者
Tejada, ML
Yu, LL
Dong, JY
Jung, K
Meng, G
Peale, FV
Frantz, GD
Hall, L
Liang, XH
Gerber, HP
Ferrara, N
机构
[1] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA
[3] Genentech Inc, Dept Bioinformat & Assay, San Francisco, CA 94080 USA
[4] Genentech Inc, Dept Automat Technol, San Francisco, CA 94080 USA
关键词
D O I
10.1158/1078-0432.CCR-05-1770
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Activated fibroblasts are thought to play important roles in the progression of many solid tumors, but little is known about the mechanisms responsible for the recruitment of fibroblasts in tumors. Using several methods, we identified platelet-derived growth factor A (PDGFA) as the major fibroblast chemoattractant and mitogen from conditioned medium generated by the Calu-6 lung carcinoma cell line. In addition, we showed that Calu-6 tumors express significant levels of PDGFC, and that the levels of expression of these two PDGFR alpha ligands correlate strongly with the degree of stromal fibroblast infiltration into the tumor mass. The most intense expression of PDGFRa was observed in fibroblasts in the tumor outer rim. We subsequently showed that disrupting PDGFR alpha-mediated signaling results in significant inhibition of tumor growth in vivo. Furthermore, analysis of a compendium of microarray data revealed significant expression of PDGFA, PDGFC, and PDGFR alpha in human lung tumors. We propose that therapies targeting this stromal cell type may be effective in treating certain types of solid tumors.
引用
收藏
页码:2676 / 2688
页数:13
相关论文
共 56 条
[1]   Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors [J].
Abramsson, A ;
Lindblom, P ;
Betsholtz, C .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (08) :1142-1151
[2]   Magnetic resonance imaging and confocal microscopy studies of magnetically labeled endothelial progenitor cells trafficking to sites of tumor angiogenesis [J].
Arbab, Ali S. ;
Frenkel, Victor ;
Pandit, Sunil D. ;
Anderson, Stasia A. ;
Yocum, Gene T. ;
Bur, Monica ;
Khuu, Hanh M. ;
Read, Elizabeth J. ;
Frank, Joseph A. .
STEM CELLS, 2006, 24 (03) :671-678
[3]   COMPARISON OF BIOLOGICAL PROPERTIES AND TRANSFORMING POTENTIAL OF HUMAN PDGF-A AND PDGF-B CHAINS [J].
BECKMANN, MP ;
BETSHOLTZ, C ;
HELDIN, CH ;
WESTERMARK, B ;
DIMARCO, E ;
DIFIORE, PP ;
ROBBINS, KC ;
AARONSON, SA .
SCIENCE, 1988, 241 (4871) :1346-1349
[4]   Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors [J].
Bergers, G ;
Song, S ;
Meyer-Morse, N ;
Bergsland, E ;
Hanahan, D .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (09) :1287-1295
[5]   Stromal fibroblasts in cancer initiation and progression [J].
Bhowmick, NA ;
Neilson, EG ;
Moses, HL .
NATURE, 2004, 432 (7015) :332-337
[6]   Design of GFB-111, a platelet-derived growth factor binding molecule with antiangiogenic and anticancer activity against human tumors in mice [J].
Blaskovich, MA ;
Lin, Q ;
Delarue, FL ;
Sun, J ;
Park, HS ;
Coppola, D ;
Hamilton, AD ;
Sebti, SM .
NATURE BIOTECHNOLOGY, 2000, 18 (10) :1065-1070
[7]   Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-αα and -αβ receptors [J].
Cao, RH ;
Bråkenhielm, E ;
Li, XR ;
Pietras, K ;
Widenfalk, J ;
Östman, A ;
Eriksson, U ;
Cao, YH .
FASEB JOURNAL, 2002, 16 (12) :1575-1583
[8]   Fibroblast growth factor 2 activation of stromal cell vascular endothelial growth factor expression and angiogenesis [J].
Claffey, KP ;
Abrams, K ;
Shih, SC ;
Brown, LF ;
Mullen, A ;
Keough, M .
LABORATORY INVESTIGATION, 2001, 81 (01) :61-75
[9]  
COLTRERA MD, 1995, CANCER RES, V55, P2703
[10]   The stroma reaction myofibroblast:: a key player in the control of tumor cell behavior [J].
Desmoulière, A ;
Guyot, C ;
Gabbiani, C .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY, 2004, 48 (5-6) :509-517